Mastermind: Tim Knotnerus (Agomab): Learnings from Agomab's recent $208 mio NASDAQ IPO

Name: Mastermind: Tim Knotnerus (Agomab): Learnings from Agomab's recent $208 mio NASDAQ IPO — LifeScienceORG
Start: 2026-05-13T12:00:00+0300
End: 2026-05-13T13:00:00+0300

Wednesday 13 May 2026
12:00 13:00

Google Calendar ICS

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations.

Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Tagged: mastermind

12 May

INSIGHTS: Jennifer Garvey Berger (Cultivating Leadership): Unlocking Leadership Mindtraps

4 June

Mastermind: Tim Knotnerus (Agomab): Learnings from Agomab's recent $208 mio NASDAQ IPO

INSIGHTS: Jennifer Garvey Berger (Cultivating Leadership): Unlocking Leadership Mindtraps

The CEO Clinic: Pascale Witz (Chair) - How CEOs keep the board’s confidence… or lose it